This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Patient Volumes Aid Community Health's (CYH) Q3 Earnings?
by Zacks Equity Research
Community Health's (CYH) third-quarter results are likely to benefit from improved payer mix and growing surgery volumes, partly offset by a decline in patient days.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Improving Industry Trends
by Kaibalya Pravo Dey
Cost optimization efforts and rising patient volumes for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving occupancy rates.
Community Health (CYH), Mindoula to Offer Mental Health Care
by Zacks Equity Research
Community Health (CYH) collaborates with Mindoula to enhance the availability of behavioral health resources to its affiliated provider network, who can now treat patients better.
Community Health Systems (CYH) Down 31.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Q2 Earnings Top on Rising Admissions
by Zacks Equity Research
Community Health (CYH) expects net operating revenues in the range of $12,200 million-$12,600 million for 2023.
Compared to Estimates, Community Health Systems (CYH) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Community Health Systems (CYH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 24.14% and 3.22%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 14.29% and 3.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Humana (HUM) Q2 Earnings Beat on Strong Pharmacy Business?
by Zacks Equity Research
Humana's (HUM) second-quarter results are likely to reflect rising premiums and investment income.
HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 0.23% and 1.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Conifer Weakness Affect Tenet Healthcare's (THC) Q2 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.
Community Health Systems (CYH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Corebridge Financial, Redfin and Community Health
by Zacks Equity Research
Corebridge Financial, Redfin and Community Health are included in this Analyst Blog.
Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 2.02% and 1.29%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Higher Costs Affect HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to reflect increased patient volumes, occupancy rate and cost of supplies.
3 Must-Buy Under $20 Stocks as Inflation Subsides
by Abhinab Dasgupta
CRBG, RDFN and CYH are three of the best and cheapest stocks that have long-term prospects and can be invested in.
Will Carelon Growth Aid Elevance Health's (ELV) Q2 Earnings?
by Zacks Equity Research
Elevance Health's (ELV) second-quarter results are likely to reflect rising memberships in Medicare Advantage, Medicaid, Vision and Dental Administration businesses.
Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q2 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) second-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues, as well as the number of people served.
Will High Medical Costs Affect UnitedHealth (UNH) Q2 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) second-quarter results are likely to reflect growth in memberships and expense levels.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
4 Hospital Stocks in Focus Amid Improving Industry Trends
by Kaibalya Pravo Dey
Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.
Community Health Systems (CYH) Down 16% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Stock Down 41.9% Since Q1 Earnings Release
by Zacks Equity Research
Community Health's (CYH) Q1 results reflect deteriorating metrics like patient days, length of stay and occupancy rates. However, rising admissions partially offset the negatives.
Community Health Systems (CYH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -95.46% and 3.09%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?